Yu Luo

Dr. Yu Luo

Ophthalmology, Chinese PLA General Hospital, Beijing, China
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YLYu Luo
Yu Luo
GXGuangcan Xu
Guangcan Xu
HLHongyu Li
Hongyu Li
TMTianju Ma
Tianju Ma
ZYZi Ye
Zi Ye
ZLZhaohui Li
Zhaohui Li
The fluidics system is an indispensable and primary component of phacoemulsification. Both the gravity-fluidics system and active-fluidics system are commonly used in practice. The irrigation pressure of the gravity-fluidics system is determined by the bottle height, which is relatively constant, while the active-fluidics system is paired with a cassette that contains pressure sensors to monitor intraocular pressure changes. The active-fluidics system allows surgeons to preset a target intraocular pressure value, and it replenishes the fluids proactively; thus, the intraocular pressure is consistently maintained near the target value. Under such circumstances, stable intraocular pressure and anterior chamber volume values could be acquired. Research on surgical safety, efficiency and results have reported several strengths of the active-fluidics system. It is also advantageous in some complicated cataract surgeries. However, the system is not widely used at present, mainly due to its low penetration rate and high equipment cost. Some of its updates such as the new Active Sentry handpiece showed potential superiority in laboratory studies recently, but there is still further research to be conducted. This article gives an overview of the mechanism and performance of the active-fluidics system, and it is expected to provide clues for future research.

26 January 2022 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
YLYu Luo
Yu Luo
HLHongyu Li
Hongyu Li
LGLixiong Gao
Lixiong Gao
JDJinlin Du
Jinlin Du
WCWenqian Chen
Wenqian Chen
ZLZhaohui Li
Zhaohui Li

15 July 2022 in Annals of Medicine
Verified
Journal Article
Open access
YLYu Luo
Yu Luo
HLHongyu Li
Hongyu Li
WCWenqian Chen
Wenqian Chen
YGYi Gao
Yi Gao
TMTianju Ma
Tianju Ma
ZLZhaohui Li
Zhaohui Li
To figure out the efficacy, effects, safety and patient’s subjective perceptions of phacoemulsification with the active-fluidics system (AFS).This was a prospective, randomized, double-masked, cont...

20 January 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
YLYu Luo
Yu Luo
HLHongyu Li
Hongyu Li
WCWenqian Chen
Wenqian Chen
YGYi Gao
Yi Gao
TMTianju Ma
Tianju Ma
ZLZhaohui Li
Zhaohui Li
Introduction The active-fluidics system is a new irrigation system of phacoemulsification that automatically detects and maintains stable intraocular pressure at the set value. This trial is designed to compare the efficacy, visual outcomes, safety and patients’ subjective perceptions of cataract surgery with the active-fluidics system and gravity-fluidics system. Methods and analysis This trial will recruit 110 patients with age-related cataract at the Chinese People’s Liberation Army (PLA) General Hospital (Beijing, China) and they will be randomly assigned to the active-fluidics group and gravity-fluidics group in a ratio of 1:1 to have phacoemulsification. Patients will be followed up at 1 day, 1 week, 1 month and 3 months postoperatively. The primary outcomes are the cumulative dissipated energy and best corrected visual acuity. Secondary outcomes include: estimated fluid usage, U/S time, total aspiration time, intraocular pressure, corneal endothelium parameters, retinal thickness, macular superficial vessel density, pain scores, scores of the Cataract surgery Patient-Reported Outcome Measures Questionnaire and the complication rates. The data will be independently analysed by the statistical team, who will be masked for the allocation information as participants are. Ethics and dissemination This study was approved by the Ethics Committee of Chinese PLA General Hospital (approval no. S2021-068-01). Informed consent will be obtained from each participant. All the results will be published in peer-reviewed journals and used for scholarly communication or technical guidance. Protocol version 1.0. Trial registration number Chinese Clinical Trial Registry (ChiCTR2100044409).

6 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YLYu Luo
Yu Luo
GXGuangcan Xu
Guangcan Xu
HLHongyu Li
Hongyu Li
TMTianju Ma
Tianju Ma
ZYZi Ye
Zi Ye
ZLZhaohui Li
Zhaohui Li
Background: Corneal edema (CE) affects the outcome of phacoemulsification. Effective ways to predict the CE after phacoemulsification are needed. Methods: On the basis of data from patients conforming to the protocol of the AGSPC trial, 17 variables were selected to predict CE after phacoemulsification by constructing a CE nomogram through multivariate logistic regression, which was improved via variable selection with copula entropy. The prediction models were evaluated using predictive accuracy, the area under the receiver operating characteristic curve (AUC), and decision curve analysis (DCA). Results: Data from 178 patients were used to construct prediction models. After copula entropy variable selection, which shifted the variables used for prediction in the CE nomogram from diabetes, best corrected visual acuity (BCVA), lens thickness and cumulative dissipated energy (CDE) to CDE and BCVA in the Copula nomogram, there was no significant change in predictive accuracy (0.9039 vs. 0.9098). There was also no significant difference in AUCs between the CE nomogram and the Copula nomogram (0.9637, 95% CI 0.9329–0.9946 vs. 0.9512, 95% CI 0.9075–0.9949; p = 0.2221). DCA suggested that the Copula nomogram has clinical application. Conclusions: This study obtained a nomogram with good performance to predict CE after phacoemulsification, and showed the improvement of copula entropy for nomogram models.

9 October 2025 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
HLHongyu Li
Hongyu Li
YYYuhan Yan
Yuhan Yan
HYHao Yan
Hao Yan
YLYu Luo
Yu Luo
HWHaiyang Wang
Haiyang Wang
WYWen Yue
Wen Yue
Cadmium, a heavy metal environmental toxin known for its neurotoxic effects on the central nervous system, is implicated in multiple eye diseases, including cataracts, glaucoma, and age-related macular degeneration. However, due to the lack of suitable experimental models, there is limited data on the impact of cadmium exposure on human retinal development. Human retinal organoids accurately mimic the 3D architecture of early fetal retinal tissue, making them suitable for investigating developmental retinal toxicity in the context of maternal cadmium exposure. This study found that cadmium exposure caused a dose- and time-dependent reduction in neural retina thickness and retinal organoid volume. And cadmium exposure specifically induced retinal cell apoptosis, inhibited retinal progenitor cell proliferation, and affected ganglion cell differentiation. After four weeks of cadmium exposure, retinal organoids exhibited abnormal cell distribution, disorganized neural retina structure, and generated rosette-like structures. Transcriptomic analysis revealed that cadmium exposure upregulated the expression of metallothioneins, profoundly disrupted ion homeostasis in retinal cells, and potentially suppressed the development of human retinal organoid by modulating pathways involved in environmental information processing. Overall, this study established a versatile and straightforward experimental model for assessing the influence of environmental toxic substances on human embryonic retinal development, and preliminarily elucidated the toxic effects and molecular mechanisms of long-term, low-dose cadmium exposure on the initial neurogenesis of the human retina.